FR145715, a novel histamine H 2 receptor antagonist, with specific anti-Helicobacter pylori activities

Author： Ishikawa H.   Ito H.   Higaki M.   Higaki M.   Matsumoto Y.   Kamimura T.   Katsura Y.   Tomishi T.   Inoue Y.   Takasugi H.   Tomoi M.   Krakowka S.   Yoshida K.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.378, Iss.3, 1999-08, pp. : 299-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel anti-Helicobacter pylori agents

By Chen W.   Cho C-H.   Chadwick V.S.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1221-1232

Informa Healthcare

Access to resources Recommend Favorite

Anti-Helicobacter pylori Agents. An Update

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 2, 2004-02 ,pp. : 201-206

Bentham Science Publishers

Access to resources Recommend Favorite

Decision Analysis of Histamine H-Receptor Antagonist Maintenance Therapy Versus Helicobacter pylori Eradication Therapy: A Randomised Controlled Trial in Patients with Continuing Pain After Duodenal Ulcer

By Tavakoli M.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 355-365

Adis International

Access to resources Recommend Favorite

Pharmacological properties of -mangostin, a novel histamine H 1 receptor antagonist

By Chairungsrilerd N.   Furukawa K.-I.   Ohta T.   Nozoe S.   Ohizumi Y.  

European Journal of Pharmacology, Vol. 314, Iss. 3, 1996-10 ,pp. : 351-356

Elsevier

Access to resources Recommend Favorite

Anti-Helicobacter pylori activities of Eucalyptus grandis: Effects on susceptibility, urease activity and cell surface hydrophobicity

By Adeniyi Bolanle   Onwubuche B. C.   Anyiam F. M.   Ekundayo O.   Mahady Gail  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 47, Iss. 1, 2009-01 ,pp. : 13-17

Informa Healthcare

Access to resources Recommend Favorite